11 September, 2014    Palm Beach FL , USA
Classical clinical trials and conclusions drawn from them are seen as not always useful aid for health care decision-making. The real-world data should provide the missing piece of information.

Recently, there has been a growing need for Real-world evidence in the pharmaceutical HEOR world. Classical clinical trials and conclusions drawn from them are seen as not always useful aid for health care decision-making. The real-world data should provide the missing piece of information. More than a decade-long RWD study of AstraZeneca is now showing the first results – the comparative study helped to reduce the annual rate of moderate to severe exacerbations by 26%.

Analyzing real-world data for health economics evaluations is still a young discipline and is still facing various organizational and educational challenges. How to improve the stakeholder dialog?
Is your process in using RWD in coverage and reimbursement decision making successful enough? Join our webinar and learn!

> Find out about different approach to RWD and pricing & reimbursement methods
> Benchmark best processes in using RWD in coverage and reimbursement decisions
> Discuss points of view of different stakeholders

Venue

Location: Webinar Venue
Contact none Palm Beach , USA
none

Organizer

Kakushin Group
+421257272174

Related events